Clinical Trial Update: MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial of magnesium-based bioresorbable scaffold for ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• MAGnesium-based bioresorbable scaffold (magnesium-based bioresorbable scaffold)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Acute Coronary Syndrome, ST Segment Elevation Myocardial Infarction | Phase 3 | Status: COMPLETED